Royal Canin Names Global Chief Medical Officer
Royal Canin USA has named Brent Mayabb, DVM, as its global chief medical officer. He previously severed as the company’s chief veterinary officer and vice president of corporate affairs.
“After 15 years with the Royal Canin USA business, Dr. Mayabb brings an abundance of passion and knowledge on nutrition for cats and dogs to his new role as global chief medical officer for Royal Canin,” said Kamie Eckert, president of Royal Canin USA in St. Charles, Mo. “There is no one better suited than Dr. Mayabb for this newly created role; Brent has been an ambassador for the company externally, and internally he has led change to support the rapid growth of our organization.”
In his new role, Mayabb will join the Royal Canin global research and development and veterinary pillar team, and will be responsible for being the medical liaison between Royal Canin and large veterinary practice groups across the globe.
“Over the last six years in my current role, I’ve had the opportunity to collaborate and build relationships with many types of organizations across the U.S. veterinary industry,” Mayabb said. “I’m excited to now work with veterinary businesses across the globe in partnership to improve the lives of cats and dogs.”
Royal Canin is a subsidiary of Mars Inc.